Position history for BlackRock, Inc.'s holdings in XENON PHARMACEUTICALS INC
BlackRock, Inc. holds 5.6M shares of XENE (XENON PHARMACEUTICALS INC), worth $328M as of 2026-Q1. The position was increased (+10.6% shares). XENE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$328M
Current Shares
5.6M
Total Value Change
+$245.4M
Total Shares Change
+3.5M
Other major holders of XENE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 5.6M |
+10.6% |
| $328M |
| 0.0% |
| $43.79 |
34 |
| 2025-Q4 | Increased | 5.1M | +6.9% | $228.6M | 0.0% | $44.12 | 33 |
| 2025-Q3 | Decreased | 4.8M | -11.1% | $191.6M | 0.0% | $39.06 | 0 |
| 2025-Q2 | Increased | 5.4M | +163.5% | $167.9M | 0.0% | $32.40 | 49 |
| 2025-Q1 | Decreased | 2M | -3.3% | $68.3M | 0.0% | $34.26 | 0 |
| 2024-Q4 | New | 2.1M | - | $82.5M | 0.0% | $38.53 | 41 |